CFB
ZBH icon

Cullen/Frost Bankers’s Zimmer Biomet ZBH Stock Holding History

Cullen/Frost Bankers’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33K Buy
383
+283
+283% +$24.8K ﹤0.01% 969
2026
Q1 		$9.04K Sell
100
-994
-91% -$91.2K ﹤0.01% 1124
2025
Q4 		$98.4K Buy
1,094
+804
+277% +$76.2K ﹤0.01% 685
2025
Q3 		$28.5K Buy
290
+116
+67% +$11.5K ﹤0.01% 869
2025
Q2 		$15.9K Sell
174
-152
-47% -$14.7K ﹤0.01% 955
2025
Q1 		$36.9K Buy
326
+305
+1,452% +$32.6K ﹤0.01% 765
2024
Q4 		$2.22K Sell
21
-529
-96% -$56.8K ﹤0.01% 1137
2024
Q3 		$59.4K Sell
550
-16
-3% -$1.75K ﹤0.01% 681
2024
Q2 		$61.4K Buy
566
+16
+3% +$1.89K ﹤0.01% 649
2024
Q1 		$72.6K Hold
550
– – ﹤0.01% 603
2023
Q4 		$66.9K Sell
550
-1,100
-67% -$123K ﹤0.01% 619
2023
Q3 		$185K Sell
1,650
-242
-13% -$30.7K ﹤0.01% 510
2023
Q2 		$275K Sell
1,892
-403
-18% -$54.8K ﹤0.01% 469
2023
Q1 		$297K Buy
2,295
+616
+37% +$77.3K 0.01% 451
2022
Q4 		$214K Sell
1,679
-552
-25% -$64.1K ﹤0.01% 489
2022
Q3 		$233K Sell
2,231
-65
-3% -$7.13K 0.01% 482
2022
Q2 		$241K Sell
2,296
-100
-4% -$11.9K 0.01% 479
2022
Q1 		$306K Sell
2,396
-72
-3% -$8.68K 0.01% 467
2021
Q4 		$304K Sell
2,468
-857
-26% -$112K 0.01% 476
2021
Q3 		$472K Hold
3,325
– – 0.01% 402
2021
Q2 		$519K Hold
3,325
– – 0.01% 392
2021
Q1 		$517K Sell
3,325
-12
-0.4% -$1.86K 0.01% 380
2020
Q4 		$499K Sell
3,337
-9
-0.3% -$1.27K 0.01% 360
2020
Q3 		$442K Buy
3,346
+1,142
+52% +$149K 0.01% 352
2020
Q2 		$255K Buy
2,204
+36
+2% +$4.15K 0.01% 414
2020
Q1 		$213K Sell
2,168
-117
-5% -$15.3K 0.01% 354
2019
Q4 		$332K Sell
2,285
-7
-0.3% -$966 0.01% 357
2019
Q3 		$306K Buy
2,292
+192
+9% +$24.8K 0.01% 358
2019
Q2 		$240K Sell
2,100
-3
-0.1% -$351 0.01% 384
2019
Q1 		$260K Sell
2,103
-108
-5% -$12.3K 0.01% 362
2018
Q4 		$223K Sell
2,211
-88
-4% -$9.9K 0.01% 366
2018
Q3 		$294K Sell
2,299
-95
-4% -$11.3K 0.01% 348
2018
Q2 		$259K Sell
2,394
-120
-5% -$13.1K 0.01% 376
2018
Q1 		$266K Buy
2,514
+96
+4% +$11.1K 0.01% 368
2017
Q4 		$284K Sell
2,418
-603
-20% -$68.2K 0.01% 333
2017
Q3 		$343K Sell
3,021
-7,946
-72% -$917K 0.01% 317
2017
Q2 		$1.37M Buy
10,967
+966
+10% +$115K 0.05% 225
2017
Q1 		$1.19M Sell
10,001
-2,683
-21% -$304K 0.04% 228
2016
Q4 		$1.27M Sell
12,684
-8,576
-40% -$919K 0.04% 226
2016
Q3 		$2.68M Buy
21,260
+11,619
+121% +$1.44M 0.1% 171
2016
Q2 		$1.13M Hold
9,641
– – 0.04% 232
2016
Q1 		$998K Buy
9,641
+4,924
+104% +$476K 0.04% 235
2015
Q4 		$470K Buy
4,717
+1,920
+69% +$188K 0.02% 275
2015
Q3 		$255K Buy
2,797
+1
+0% +$100 0.01% 345
2015
Q2 		$297K Buy
2,796
+3
+0.1% +$332 0.01% 346
2015
Q1 		$319K Buy
2,793
+103
+4% +$11.8K 0.01% 336
2014
Q4 		$296K Sell
2,690
-6
-0.2% -$632 0.01% 347
2014
Q3 		$263K Buy
2,696
+83
+3% +$8.16K 0.01% 347
2014
Q2 		$263K Buy
2,613
+24
+0.9% +$2.34K 0.01% 344
2014
Q1 		$238K Hold
2,589
– – 0.01% 349
2013
Q4 		$235K Hold
2,589
– – 0.01% 343
2013
Q3 		$207K Buy
+2,589
New +$204K 0.01% 364

Other funds holding ZBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Cullen/Frost Bankers's ZBH Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Zimmer Biomet (ZBH) stake by 283% in Q2 2026, buying an estimated $24.8K and bringing the position to 383 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #969.

Cullen/Frost Bankers first reported a position in ZBH in Q3 2013 and has held it in 52 quarters since. The position peaked at $2.68M in Q3 2016. 490 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Cullen/Frost Bankers held 383 shares of Zimmer Biomet worth $33K as of Q2 2026.
  • Cullen/Frost Bankers bought 283 Zimmer Biomet shares in Q2 2026, an estimated $24.8K.
  • Zimmer Biomet made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #969 holding.
  • Cullen/Frost Bankers first reported a position in Zimmer Biomet in Q3 2013 and has held it in 52 quarters since.
  • Cullen/Frost Bankers's Zimmer Biomet position peaked at $2.68M in Q3 2016.
  • 490 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.